Product Specifications
| Catalog Number | BIC-7018E |
|---|---|
| Target | Bone morphogenetic protein 7 |
| Target Symbol | BMP7 |
| Species | Human |
| Expression System | CHO |
| Expression Region | Met316-His431 |
| Molecular Weight | 13.1 kDa |
| Purity | ≥95%, by SDS-PAGE (under reducing (R) & Non-reducing conditions, visualized by Coomassie staining). |
| Endotoxin | ≤10 EU/mg by the LAL method. |
| Formulation | Lyophilized |
| Buffer | Lyophilized from a 0.22 μm-filtered solution containing 0.085% TFA, 30% ACN, 5% Mannitol. |
| Reconstitution | It is recommended to redissolve in 4 mM HCl. |
| Storage & Stability | 36 months at-20°C to -80°C in lyophilized state; 6 months at -20°C to -80°C under sterile conditions after reconstitution; 7-10 days at 2°C to 8°C under sterile conditions after reconstitution; Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipping | The product is shipped with blue ice. |
| Lead Time | Products are in stock, but custom products may require further consultation. |
| Accession | P18075 |
| Alternative Names | Bone morphogenetic protein 7; BMP-7; Osteogenic protein 1 (OP-1); Eptotermin alfa; BMP7; OP1 |
Bioactivity
Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is 0.02-0.04 μg/mL.
Quality Data
Recombinant Human BMP-7 (Cat. No. BIC-7018E) was analyzed by SDS-PAGE.
